title: Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis.
authors.affiliation: Instituto de Estudios de Mastocitosis de Castilla La Mancha, Toledo, Spain. Electronic address: amatito@sescam.jccm.es.
authors.forename: Almudena
authors.initials: A
authors.lastname: Matito
authors.forename: Cristina
authors.initials: C
authors.lastname: Blázquez-Goñi
authors.forename: Jose M
authors.initials: JM
authors.lastname: Morgado
authors.forename: Iván
authors.initials: I
authors.lastname: Alvarez-Twose
authors.forename: Manuela
authors.initials: M
authors.lastname: Mollejo
authors.forename: Laura
authors.initials: L
authors.lastname: Sánchez-Muñoz
authors.forename: Luis
authors.initials: L
authors.lastname: Escribano
mesh_terms: D000293:Adolescent; D000818:Animals; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy / Q000276:immunology; D005260:Female; D006801:Humans; D034701:Mastocytosis, Cutaneous / Q000188:drug therapy*; D000069444:Omalizumab; D039981:Pyroglyphidae / Q000276:immunology
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab